1 Corporate Drive
South San Francisco, CA 94080
Soley’s innovative evaluation platform decodes Cellular Language at scale for efficient drug discovery and development.
Soley Therapeutics is the brainchild of cardiologist Yerem Yeghiazarians, MD, and molecular cancer biologist Kurosh Ameri, PhD. They began working together in 2010 to answer the question “how do cells determine their fate?”
Soley’s groundbreaking high-throughput platform technology uses the cell as a natural sensor. It harnesses cells’ anticipatory biological capabilities, and utilizes the power of AI/ML to discover and develop drugs efficiently and effectively.
Co-Founder, CEO, Board Member